Avalo Therapeutics, Inc. · NASDAQ:AVTX
Commodore Capital LP reported a 9.90% stake in Avalo Therapeutics, Inc. (Schedule 13G)
Event Jun 11, 2026 · Filed Jun 18, 2026
Commodore Capital LP reported a 9.90% stake in Avalo Therapeutics, Inc., 5,721,109 shares, as a passive investor on Jun 11, 2026. Filed Jun 18, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 5,721,109
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 5,721,109 |
| Commodore Capital Master LP | 9.90% | 5,721,109 |
| Robert Egen Atkinson | 9.90% | 5,721,109 |
| Michael Kramarz | 9.90% | 5,721,109 |